Year None202120202019201820172016 May 28, 2021 Medicenna Reports Fiscal Year 2021 Financial Results and Operational Highlights Go to May 20, 2021 Medicenna to Announce Fiscal Year 2021 Financial Results and Operational Highlights on Friday, May 28, 2021 Go to May 12, 2021 Medicenna Appoints Immuno-Oncology Expert Dr. Mann Muhsin as Chief Medical Officer Go to May 7, 2021 Medicenna Announces the Peer-Reviewed Publication of Clinical Data from Phase 2b Trial Evaluating MDNA55 in Recurrent Glioblastoma Go to April 21, 2021 Medicenna Therapeutics Announces the Appointment of Industry Veteran, Kevin Moulder, PhD, as Chief Scientific Officer Go to April 14, 2021 Medicenna to Present at the Bloom Burton & Co. Healthcare Investor Conference Go to Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
May 20, 2021 Medicenna to Announce Fiscal Year 2021 Financial Results and Operational Highlights on Friday, May 28, 2021 Go to
May 12, 2021 Medicenna Appoints Immuno-Oncology Expert Dr. Mann Muhsin as Chief Medical Officer Go to
May 7, 2021 Medicenna Announces the Peer-Reviewed Publication of Clinical Data from Phase 2b Trial Evaluating MDNA55 in Recurrent Glioblastoma Go to
April 21, 2021 Medicenna Therapeutics Announces the Appointment of Industry Veteran, Kevin Moulder, PhD, as Chief Scientific Officer Go to
